Literature DB >> 12704492

Contemporary burden of illness of congestive heart failure in Canada.

Ross T Tsuyuki1, Marcelo C Shibata, Carolyn Nilsson, Marilou Hervas-Malo.   

Abstract

BACKGROUND: Congestive heart failure (CHF) is associated with high morbidity and mortality; however, there is little contemporary Canadian data to quantify the burden of this illness.
OBJECTIVE: To report the impact of CHF in Canada, as measured by hospitalizations.
METHODS: Data were obtained from the Canadian Institute for Health Information on patients hospitalized with CHF as a most responsible, primary or complication diagnosis during fiscal year 2000/01.
RESULTS: There were a total of 106,130 discharges for 85,679 CHF patients in the fiscal year 2000/01. Total in-hospital mortality was 15.8%. In terms of total discharges for CHF, 32.7% were readmissions. On an individual patient basis, 19.9% of patients were rehospitalized once or more during 2000. In terms of burden of illness of CHF compared with other major illnesses, CHF is associated with the second highest total number of hospital days and third highest number of patients affected.
CONCLUSIONS: Hospitalization for CHF occurs frequently and accounts for a large number of hospital bed-days in Canada. These figures should signal a call to action for researchers, administrators and health care providers regarding the need for more efficacious therapies, better application of already-proven therapies and patient education.

Entities:  

Mesh:

Year:  2003        PMID: 12704492

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  13 in total

1.  Multidisciplinary heart failure clinics: are they effective in Canada?

Authors:  Michael W Rich
Journal:  CMAJ       Date:  2005-07-05       Impact factor: 8.262

2.  A qualitative study of the contribution of pharmacists to heart failure management in Scotland.

Authors:  Alexander M Clark; John J V McMurray; Caroline E Morrison; David L Murdoch; Simon Capewell; Margaret E Reid
Journal:  Pharm World Sci       Date:  2005-12

3.  Revascularization in patients with heart failure.

Authors:  Ross T Tsuyuki; Fiona M Shrive; P Diane Galbraith; Merril L Knudtson; Michelle M Graham
Journal:  CMAJ       Date:  2006-08-15       Impact factor: 8.262

4.  Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007.

Authors:  Darwin F Yeung; Nicole K Boom; Helen Guo; Douglas S Lee; Susan E Schultz; Jack V Tu
Journal:  CMAJ       Date:  2012-08-20       Impact factor: 8.262

5.  Two decades of cardiac transplantation at the Montreal Heart Institute.

Authors:  Frédéric Jacques; Michel Carrier; Guy B Pelletier; Michel White; Normand Racine; Michel Pellerin; Denis Bouchard; Philippe Demers; Louis P Perrault
Journal:  Can J Cardiol       Date:  2008-03       Impact factor: 5.223

6.  Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failure.

Authors:  Soko Setoguchi; Anju Nohria; Jeremy A Rassen; Lynne Warner Stevenson; Sebastian Schneeweiss
Journal:  CMAJ       Date:  2009-03-17       Impact factor: 8.262

Review 7.  Acute decompensated heart failure.

Authors:  Serge Lepage
Journal:  Can J Cardiol       Date:  2008-07       Impact factor: 5.223

8.  Practice patterns and outcomes in patients presenting to the emergency department with acute heart failure.

Authors:  Crystal A Richter; Jeanrian Claude M Kalenga; Brian H Rowe; Lauren C Bresee; Ross T Tsuyuki
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

Review 9.  Pathobiology of cardiac dyssynchrony and resynchronization.

Authors:  David A Kass
Journal:  Heart Rhythm       Date:  2009-08-14       Impact factor: 6.343

10.  Hemodynamic, management, and outcomes of patients admitted to emergency department with heart failure.

Authors:  Pierre-Géraud Claret; Ian G Stiell; Justin W Yan; Catherine M Clement; Brian H Rowe; Lisa A Calder; Jeffrey J Perry
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-11-07       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.